Упрощенная HTML-версия
359. Evaluation of Tick-Borne Encephalitis DNA Vaccines in Monkeys / C. Schmaljohn
[et al.] // Virology. —1999. —Vol. 263, № 1. —P. 166-174.
360. Failure of postexposure treatment of rabies in children / H. Wilde [et al.] // Clin.
Infect. Dis. - 1996. - Vol. 22. - P. 228-232.
361. Fan, W. F. Membrane association and secretion of the Japanese encephalitis
virus NS1 protein from cells expressing NS1 cDNA / W. F. Fan, P. W. Mason //
Virology. - 1990. - Vol. 177. - P. 470-476.
362. Fridmann, W. Regulation of В-cell activation and antigen precentation by Fc
receptors / W. Fridmann // Curr. Opin. Immunol. - 1993. - Vol. 5. - P. 355-360.
363. Generation and characterization of human monoclonal neutralizing antibodies with
distinct binding and sequence features against SARS coronavirus using XenoMouse
/ M. Coughlin [et al.] // Virology. - 2007. - Vol. 361. - P. 93-102.
364. Generation of neutralizing human monoclonal antibodies against parvovirus В 19
proteins / A. Gigler [et al.] // J. Virol. - 1999. - Vol. 73. - P. 1974-1979.
365. Gibson, C. A. Prospects for a virus non-structural protein as a subunit vaccine /
C. A. Gibson, J. J. Schlesinger, A. D. Barrett // Vaccine. - 1988. - № 6, № 1. —
P. 7-9.
366. Givner, L. B. Monoclonal antibodies against respiratory syncytial virus /
L. B. Givner// Pediatr. Infect. Dis. J. - 1999. - Vol. 18. - P. 541-542.
367. Glowacki, L. S. Use of immune globulin to prevent symptomatic cytomegalovirus
disease in transplant recipientsa meta-analysis / L. S. Glowacki, F. M. Smaill. //
Clin. Transplant. - 1994. - Vol. 8. - P. 10-18.
368. Guidance document on use o f medicinal products for treatment and prophylaxis
o f biological agents that might be used as weapons of bioterrorism / ЕМЕА/
CPMP/4048/01 [Electronic resourse]. - Last Update: 1 June 2007. - Access mode:
http:/
eu/.
369. Guttieri, M.C. Expression of a human, neutralizing monoclonal antibody specific
to puumala virus G2-protein in stably-transformed insect cells / М. C. Guttieri,
C. Bookwalter, C. Schmaljohn // J. Immunol. Methods. - 2000. - Vol. 246. -
P. 97-108.
370. Hangartner, L. Antiviral antibody responses: the two extremes of a wide spectrum
/ L. Hangartner, R.M. Zinkemagel, H. Hengartner // Nat. Rev. Immunol. -
2006.
- Vol. 6, № 3. - P. 231-243.
371. Hedenstrom, M. Vaccination against tick-borne encephalitis (TBE): influence of
simultaneous application of TBE immunoglobulin on seroconversion and rate of
adverse events / M. Hedenstrom, U. Heberle, K. Theobald // Vaccine. - 1995. -
№ 13, № 8 . -P . 759-762.
372. Heinz, F.X. Tick-borne encephalitis and the impact of vaccination / F.X. Heinz,
C. Kunz // Arch. Virol. - 2004. - Vol. 18, suppl. - P. 201-205.
373. Hemming, V. G. Use of intravenous immunoglobulins for prophylaxis or treatment
of infectious diseases / V. G. Hemming // Clin. Diagn. Lab. Immunol. - 2001. -
Vol. 8. - P. 859-863.
374. Herzig, R. An uncommon severe clinical course of European tick-borne encephalitis
/ R. Herzig, С. M. Patt, T. Prokes // Biomed. Pap. Med. Fac. Univ. Palacky
Olomouc. Czech. Repub. - 2002. - Vol. 146, № 2. - P. 63-67.
375. Hoogenboom H.R. Selecting and screening recombinant antibody libraries /
H.R. Hoogenboom // Nat. Biotechnol. - 2005. - Vol. 23. - P. 1105-1116.
223